ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13

Invention Application

US20160289323A1 ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13 有权

Title translation: 具有人IL-13结合特异性的抗体分子

Please log in to see more content

Patent Title: ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13
Patent Title (中): 具有人IL-13结合特异性的抗体分子
Application No.: US15180916

Application Date: 2016-06-13
Publication No.: US20160289323A1

Publication Date: 2016-10-06
Inventor: Neil Gozzard , Alastair David Griffiths Lawson , Daniel John Lightwood , Roger Thomas Palframan , Bryan John Smith , Kerry Louise Tyson
Applicant: UCB BIOPHARMA SPRL
Priority: GB0904214.4 20090311
Main IPC: C07K16/24
IPC: C07K16/24 ; A61K9/00 ; A61K39/395

ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13

Abstract:

The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Abstract(Chinese):

本发明涉及对人IL-13的抗原决定簇具有特异性的抗体分子，抗体分子的治疗用途以及产生所述抗体分子的方法。

Public/Granted literature

US09957320B2 Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13 Public/Granted day:2018-05-01

Information query

Global Dossier Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07K	肽（含有β-内酰胺的肽入C07D；在分子中除了形成本身的肽环外不含有任何其他的肽键的环状二肽，如哌嗪-2,5-二酮入C07D；环肽型麦角生物碱入C07D519/02；单细胞蛋白质、酶入C12N；获得肽的基因工程方法入C12N15/00）
C07K16/00	免疫球蛋白，例如，单克隆或多克隆抗体
C07K16/18	.抗来自动物或人的物质
C07K16/24	..抗细胞因子，淋巴因子或干扰素